The Society for Immunotherapy of Cancer’s (SITC) Fellowship Awards program was established through the Forward Fund to support the development of young investigators in the field to cultivate the next generation of cancer immunotherapy experts.
Since 2014, SITC has committed more than $2 million in fellowship awards to deserving young investigators.
SITC is excited to offer young investigators a series of fellowship award opportunities through a new collaboration with Stand Up To Cancer (SU2C).
Early career scientists can now apply to any of the following four SU2C-SITC Convergence Scholar Awards to receive training in physical and biomedical sciences to better understand the immune system’s response to cancer.
The Scholar Awards will team postdoctoral fellows with leading experts in the fields of life and physical sciences, mathematics and engineering. The overall goal of this SITC and SU2C collaboration is to create a new type of researcher – the convergence investigator – who is trained to recognize and include all relevant scientific knowledge, no matter the specialty. The SU2C-SITC collaboration will help train young scientists in both biomedical and physical science approaches that heavily contribute towards development of novel immunotherapeutic approaches.
One additional Scholar Award will become available as part of the SU2C Convergence initiative, with application date to be announced in the near future.
SITC is pleased to announce the recipients of three 2018 Fellowship Awards, to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of novel research.
The SITC Fellowship Awards program was established through the society’s Forward Fund, which has committed more than $2 million in Fellowship Award opportunities to deserving young investigators since 2014.
The award recipients will be honored during a ceremony at the society’s 33rd Annual Meeting on Saturday, Nov. 10, 2018, at the Walter E. Washington Convention Center in Washington, D.C.
The 2018 SITC Fellowship Award recipients are:
Recipient: David Liu, MD, MPH, MS, Dana-Farber Cancer Institute
Project Title: “Dissecting Differential Response to Immunotherapy in Melanoma through Clinical Computational Oncology”
Award Amount: $200,000 (two years)
Sponsored byMade possible by an educational grant from Bristol-Myers Squibb.
Recipient: Bryan D. Choi, MD, PhD, Massachusetts General Hospital and Harvard Medical School
Project Title: “Combination Immunotherapy with Chimeric Antigen Reception T cells and Bispecific T-cell Engagers for Glioblastoma”
Award Amount: $100,000 (one year)
Sponsored byMade possible by an educational grant from AstraZeneca Pharmaceuticals LP.
Recipient: Kelly G. Paulson, MD, PhD, Fred Hutchinson Cancer Research Center
Project Title: “Turning immunotherapy responses into immunotherapy cures for the virus-associated Merkel cell carcinoma”
Sponsored byMade possible by an educational grant from Merck & Co., Inc.
Interested in supporting a fellowship? Contact SITC Development at firstname.lastname@example.org or +1 414-271-2456.
Also, visit our Frequently Asked Questions page for more details about the SITC Fellowship Awards.
Looking to view past recipients of SITC Fellowship Awards? Click the links below:
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com